These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 21787173

  • 1. Clot lysis time in platelet-rich plasma: method assessment, comparison with assays in platelet-free and platelet-poor plasmas, and response to tranexamic acid.
    Panes O, Padilla O, Matus V, Sáez CG, Berkovits A, Pereira J, Mezzano D.
    Platelets; 2012; 23(1):36-44. PubMed ID: 21787173
    [Abstract] [Full Text] [Related]

  • 2. Görög Thrombosis Test: a global in-vitro test of platelet function and thrombolysis.
    Yamamoto J, Yamashita T, Ikarugi H, Taka T, Hashimoto M, Ishii H, Watanabe S, Kovacs IB.
    Blood Coagul Fibrinolysis; 2003 Jan; 14(1):31-9. PubMed ID: 12544726
    [Abstract] [Full Text] [Related]

  • 3. Stabilization of fibrin clots by activated prothrombin complex concentrate and tranexamic acid in FVIII inhibitor plasma.
    Dai L, Bevan D, Rangarajan S, Sørensen B, Mitchell M.
    Haemophilia; 2011 Sep; 17(5):e944-8. PubMed ID: 21371192
    [Abstract] [Full Text] [Related]

  • 4. The potential role of platelet PAl-1 in t-PA mediated clot lysis of platelet rich plasma.
    Serizawa K, Urano T, Kozima Y, Takada Y, Takada A.
    Thromb Res; 1993 Aug 15; 71(4):289-300. PubMed ID: 8236158
    [Abstract] [Full Text] [Related]

  • 5. Profibrinolytic activity of the direct thrombin inhibitor melagatran and unfractionated heparin in platelet-poor and platelet-rich clots.
    Semeraro F, Piro D, Rossiello MR, Ammollo T, Colucci M.
    Thromb Haemost; 2007 Dec 15; 98(6):1208-14. PubMed ID: 18064315
    [Abstract] [Full Text] [Related]

  • 6. A history of early stent thrombosis is associated with prolonged clot lysis time.
    Pankiw-Bembenek O, Zalewski J, Goralczyk T, Undas A.
    Thromb Haemost; 2012 Mar 15; 107(3):513-20. PubMed ID: 22274545
    [Abstract] [Full Text] [Related]

  • 7. Peroxynitrite may affect fibrinolysis via the reduction of platelet-related fibrinolysis resistance and alteration of clot structure.
    Misztal T, Rusak T, Brańska-Januszewska J, Ostrowska H, Tomasiak M.
    Free Radic Biol Med; 2015 Dec 15; 89():533-47. PubMed ID: 26454084
    [Abstract] [Full Text] [Related]

  • 8. The effect of long-term, low-dose tranexamic acid treatment on platelet dysfunction and haemoglobin levels in haemodialysis patients.
    Sabovic M, Zupan IP, Salobir B, Zupan I, Cernelc P, Lavre J, Vujkovac B.
    Thromb Haemost; 2005 Dec 15; 94(6):1245-50. PubMed ID: 16411401
    [Abstract] [Full Text] [Related]

  • 9. Tranexamic acid mediates proinflammatory and anti-inflammatory signaling via complement C5a regulation in a plasminogen activator-dependent manner.
    Barrett CD, Moore HB, Kong YW, Chapman MP, Sriram G, Lim D, Moore EE, Yaffe MB.
    J Trauma Acute Care Surg; 2019 Jan 15; 86(1):101-107. PubMed ID: 30575685
    [Abstract] [Full Text] [Related]

  • 10. Increased plasma clot permeability and susceptibility to lysis are associated with heavy menstrual bleeding of unknown cause: a case-control study.
    Szczepaniak P, Zabczyk M, Undas A.
    PLoS One; 2015 Jan 15; 10(4):e0125069. PubMed ID: 25909989
    [Abstract] [Full Text] [Related]

  • 11. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.
    Colucci M, Scopece S, Gelato AV, Dimonte D, Semeraro N.
    Thromb Haemost; 1997 Apr 15; 77(4):725-9. PubMed ID: 9134650
    [Abstract] [Full Text] [Related]

  • 12. Hemostatic Therapy Using Tranexamic Acid and Coagulation Factor Concentrates in a Model of Traumatic Liver Injury.
    Zentai C, van der Meijden PE, Braunschweig T, Hueck N, Honickel M, Spronk HM, Rossaint R, Grottke O.
    Anesth Analg; 2016 Jul 15; 123(1):38-48. PubMed ID: 27192476
    [Abstract] [Full Text] [Related]

  • 13. Differential inhibition with antifibrinolytic agents of staphylokinase and streptokinase induced clot lysis.
    Lijnen HR, Stassen JM, Collen D.
    Thromb Haemost; 1995 May 15; 73(5):845-9. PubMed ID: 7482414
    [Abstract] [Full Text] [Related]

  • 14. Factor XIII and tranexamic acid but not recombinant factor VIIa attenuate tissue plasminogen activator-induced hyperfibrinolysis in human whole blood.
    Dirkmann D, Görlinger K, Gisbertz C, Dusse F, Peters J.
    Anesth Analg; 2012 Jun 15; 114(6):1182-8. PubMed ID: 22104068
    [Abstract] [Full Text] [Related]

  • 15. Altered plasma fibrin clot properties in essential thrombocythemia.
    Małecki R, Gacka M, Kuliszkiewicz-Janus M, Jakobsche-Policht U, Kwiatkowski J, Adamiec R, Undas A.
    Platelets; 2016 Jun 15; 27(2):110-6. PubMed ID: 25989112
    [Abstract] [Full Text] [Related]

  • 16. Tranexamic acid inhibits fibrinolysis, shortens the bleeding time and improves platelet function in patients with chronic renal failure.
    Mezzano D, Panes O, Muñoz B, Pais E, Tagle R, González F, Mezzano S, Barriga F, Pereira J.
    Thromb Haemost; 1999 Oct 15; 82(4):1250-4. PubMed ID: 10544908
    [Abstract] [Full Text] [Related]

  • 17. A fibrinogen concentrate Haemocomplettan (Riastap) or a Factor XIII concentrate Fibrogammin combined with a mini dose of tranexamic acid can reverse the fibrin instability to fibrinolysis induced by thrombin- or FXa-inhibitor.
    He S, Johnsson H, Zabczyk M, Hultenby K, Cao H, Blombäck M.
    Br J Haematol; 2013 Mar 15; 160(6):806-16. PubMed ID: 23360261
    [Abstract] [Full Text] [Related]

  • 18. Denser plasma clot formation and impaired fibrinolysis in paroxysmal and persistent atrial fibrillation while on sinus rhythm: association with thrombin generation, endothelial injury and platelet activation.
    Drabik L, Wołkow P, Undas A.
    Thromb Res; 2015 Aug 15; 136(2):408-14. PubMed ID: 26048399
    [Abstract] [Full Text] [Related]

  • 19. The contribution of platelets in the production of cryoprecipitates for use in a fibrin glue.
    Rock G, Neurath D, Lu M, Alharbi A, Freedman M.
    Vox Sang; 2006 Oct 15; 91(3):252-5. PubMed ID: 16958838
    [Abstract] [Full Text] [Related]

  • 20. Fibrin(ogen)olytic character of FIIa isolated from Agkistrodon acutus venom.
    Wang YW, Liang XX, Chen JS, Chen Q, Qiu PX, Lin X, Yan GM.
    Acta Pharmacol Sin; 2005 Jun 15; 26(6):691-5. PubMed ID: 15916735
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.